Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers

KANBAK G., AKALIN A., Dokumacioglu A., Ozcelik E., BAL C.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, cilt.5, sa.1, ss.7-11, 2011 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5 Sayı: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.dsx.2010.05.006
  • Dergi Adı: DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.7-11
  • Anahtar Kelimeler: Metabolic syndrome, Type 2 diabetes mellitus, Cardiovascular disease, Paraoxonase, Nitric oxide, Total sialic acid, NITRIC-OXIDE SYNTHASE, SERUM SIALIC-ACID, INSULIN-RESISTANCE, PARAOXONASE, DISEASE, ATHEROSCLEROSIS, COMPLICATIONS, INFLAMMATION, ANTIOXIDANT, INHIBITION
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objectives: Metabolic syndrome (MetS) and type 2 diabetes mellitus (DM) are associated with a high incidence of cardiovascular diseases. The aim of this study was to determine paraoxonase (PON), total sialic acid (TSA), and nitric oxide (NO) levels in addition to conventional risk markers in patients with DM, MetS and DM plus MetS.